← Back to Clinical Trials
Recruiting NCT07125144

NCT07125144 Piloting a Culturally Adapted Suicide Prevention for Black Students in Chicago

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07125144
Status Recruiting
Phase
Sponsor University of Chicago
Condition Suicide
Study Type INTERVENTIONAL
Enrollment 300 participants
Start Date 2025-01-30
Primary Completion 2026-03-31

Eligibility & Interventions

Sex All sexes
Min Age 11 Years
Max Age 15 Years
Study Type INTERVENTIONAL
Interventions
Black Youth Suicide Prevention in ChicagoSigns of Suicide: Standard/Existing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 300 participants in total. It began in 2025-01-30 with a primary completion date of 2026-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Suicide has been the third leading cause of death for Black youth in the U.S since the 1980s and persists as a leading cause of death for Black youth today. For example, in 2018 suicide was reported as the 2nd leading cause of death among Black Americans ages 10 to14 years old. Findings yielded from recent queries indicate that the gap in suicides among Black males and female youth has narrowed in recent years. Despite these disturbing trends, a dearth persists in our understanding of the factors that contribute to and prevent against suicide in Black youth, thus diminishing researchers' ability to effectively detect suicide risk in this particular population. This project aims to redress this gap by proposing the cultural adaptation of an existing suicide prevention intervention, the Signs of Suicide (SOS) prevention program, for Black middle school students. Our team will conduct a pilot randomized controlled trial among a sample of Black middle school students to assess feasibility and examine underlying mechanisms that contribute to suicidality among Black youth. Intervention content will be adapted to assess how topics of racial identity, racial socialization, and racial discrimination uniquely impact Black youth's mental health experiences and risk for suicide. Measures of suicidal ideation, planning, and attempt will be assessed at pre-test, post-test, and 3-months after the intervention. Findings derived from this project will contribute to public health priorities by offering unique insight into the factors that either prevent or promote suicide among Black youth and could be replicated in other schools serving Black students across the nation.

Eligibility Criteria

Inclusion Criteria: * Enrolled in 6th, 7th, or 8th grade at a participating school Exclusion Criteria: * Not enrolled in 6th, 7th, or 8th grade at a participating school

Contact & Investigator

Central Contact

Janelle R Goodwill, PhD

✉ jgoodwill@uchicago.edu

📞 773-834-5114

Principal Investigator

Janelle R. Goodwill, PhD

PRINCIPAL INVESTIGATOR

University of Chicago

Frequently Asked Questions

Who can join the NCT07125144 clinical trial?

This trial is open to participants of all sexes, aged 11 Years or older, up to 15 Years, studying Suicide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07125144 currently recruiting?

Yes, NCT07125144 is actively recruiting participants. Contact the research team at jgoodwill@uchicago.edu for enrollment information.

Where is the NCT07125144 trial being conducted?

This trial is being conducted at Chicago, United States.

Who is sponsoring the NCT07125144 clinical trial?

NCT07125144 is sponsored by University of Chicago. The principal investigator is Janelle R. Goodwill, PhD at University of Chicago. The trial plans to enroll 300 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology